Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City

Don C. Des Jarlais, Theresa Diaz, Theresa Perlis, David Vlahov, Carey Maslow, Mary Latka, Russell Rockwell, Vincent Edwards, Samuel R. Friedman, Edgar Monterroso, Ian Williams, Richard S. Garfein

Research output: Contribution to journalArticlepeer-review

Abstract

Cohort studies of young (aged 18-30 years) injecting drug users recruited in 1997-1999 in the Harlem and Lower East Side areas of New York City, New York, were used to assess the incidence of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV). The authors found that HIV incidence was low at both sites: 0.8/100 person-years at the Harlem site and 0/100 person-years at the Lower East Side site. In contrast, HBV incidence was moderate (12.2/100 person-years) at the Harlem site and high (30.7/100 person-years) at the Lower East Side site. Similarly, HCV incidence was moderate (9.3/100 person-years) at the Harlem site and high (34.0/100 person-years) at the Lower East Side site. Results show that high rates of HBV and HCV transmission do not imply high rates of HIV transmission, even within an area of high HIV seroprevalence.

Original languageEnglish (US)
Pages (from-to)467-471
Number of pages5
JournalAmerican Journal of Epidemiology
Volume157
Issue number5
DOIs
StatePublished - Mar 1 2003

Keywords

  • Cohort studies
  • HIV
  • Hepatitis B virus
  • Hepatitis C-like viruses
  • Injections, intravenous
  • Substance-related disorders

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City'. Together they form a unique fingerprint.

Cite this